Hopelessness the "active ingredient"? Associations of hopelessness and depressive symptoms with interleukin-6

International Journal of Psychiatry in Medicine

Volumn 46, Issue 1, 2013, Pages 109-117

  Mitchell, Amanda ^a   Pössel, Patrick ^a   Sjögren, Elaine ^b   Kristenson, Margareta ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

cross sectional study; depressive symptoms; hopelessness; interleukin 6

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CRONBACH ALPHA COEFFICIENT; DEPRESSION; DSM-IV; ENZYME IMMUNOASSAY; FEMALE; GENDER; HAMILTON SCALE; HOPELESSNESS; HUMAN; MALE; SMOKING;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HOPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SWEDEN;

EID: 84889822036     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.46.1.g     Document Type: Article

References (26)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 2006;3:2011-2030.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors. Washington, DC: World Bank & Oxford University Press, 2006.
3. Leung YW, Flora DB, Gravely S, Irvine J, Carney RM, Grace SL. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: Meta-analysis. Psychosomatic Medicine 2012;74:786-801.
4. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-1186.
5. Papanicolaou D, Wilder R, Manolagas S, Chrousos G. The pathophysiology of interleukin-6 in human disease. Annals of Internal Medicine 1998;128:127-137.
6. Mastorakos G, Chrousos G, Weber J. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. Journal of Clinical Endocrinology and Metabolism 1993;77:1690-1694.
7. Brown G, Harris T. Social origins of depression. London, UK: Tavistock, 1978.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th Edition; Text Revision) (DSM-IV-TR). Washington, DC: American Psychiatric Association, 2000.
9. Abramson LY, Metalsky GI, Alloy LB. Hopelessness depression: A theory-based subtype of depression. Psychology Review 1989;96:358-372.
10. Beck AT. Cognitive therapy and the emotional disorders. New York, NY: International University Press, 1976.
11. Whipple MO, Lewis TT, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Powell LH, Everson-Rose SA. Hopelessness, depressive symptoms, and carotid atherosclerosis in women: The Study of Women's Health Across the Nation (SWAN) Heart Study. Stroke 2009;40:3166-3172.
12. Pössel P, Mitchell AM, Ronkainen K, Kaplan GA, Kauhanen J, Valtonen M. Do depressive symptoms predict the incidence of myocardial infarction independent of hopelessness? Journal of Health and Psychology 1359105313498109, first published on August 29, 2013. doi:10.1177/1359105313498109 13.
13. Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 2000;35: 561-567.
14. Sjögren E, Leanderson P, Kristenson M, Ernerudh J. Interleukin-6 levels in relation to psychosocial factors: Studies on serum, saliva, and in vitro production by blood mononuclear cells. Brain Behavior and Immunology 2006;20:270-278.
15. Pollitt RA, Daniel M, Kaufman JS. Mediation and modification of the association between hopelessness, hostility, and progression of carotid atherosclerosis. Journal of Behavioral Medicine 2005;28:53-64.
16. Bech P. Quality of life instruments in depression. European Psychiatry 1997;12: 194-198.
17. Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychology and Medicine 2003;33:351-356.
18. Everson SA, Goldberg DE, Kaplan GA, Cohen RD, Pukkala E, Tuomilehto J, Salonen, JT. Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosomatic Medicine 1996;58:113-121.
19. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. A meta-analysis of cytokines in major depression. Biology and Psychiatry 2010; 67:446-457.
20. Pizzi C, Rutjes AWS, Costa GM, Fontana F, Mezzetti A, Manzoli L. Meta-analysis of Selective Serotonin Reuptake Inhibitors in patients with depression and coronary heart disease. American Journal of Cardiology 2011;107:972-979.
21. Pössel P, Hautzinger M. Effekte pharmakologischer und psychotherapeutischer Interventionen auf Depressionen bei Kindern und Jugendlichen. Effects of pharmacoand psychotherapeutic interventions of depression in children and adolescents. Z Kinder Jugendpsychiatr 2006;34:243-255.
22. Morton J, Snowdon S, Gopold M, Guymer E. Acceptance and commitment therapy group treatment for symptoms of borderline personality disorder: A public sector pilot study. Cognitive Behavior Practice 2012;19:527-544.
23. Townsend E, Hawton K, Altman DG, Arensman E, Gunnell D, Hazell P, House A, van Heeringen K. The efficacy of problem-solving treatment after deliverate selfharm: Meta-analysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychology and Medicine 2001;31:979-988.
24. Cole DA, Maxwell SE. Testing mediational models with longitudinal data: Questions and tips in the use of structural equation modeling. Journal of Abnormal Psychology 2003;112:558-577.
25. Do DP, Down JB, Ranjit N, House JS, Kaplan GA. Hopelessness, depression, and early markers of endothelial dysfunction in U.S. adults. Psychosomatic Medicine 2010;72:613-619.
26. Fuller-Thomson E, Brennenstuhl S, Frank J. The association between childhood physical abuse and heart disease in adulthood: Findings from a representative community sample. Child Abuse and Neglect 2010;34:689-698.